Dietary eicosapentaenoic and docosahexaenoic acids decrease prostanoids in the ileum of rats treated with irinotecan and 5-fluorouracil

doi:10.4251/wjgo.120472

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 9

This Article

(2)

(1)

(0)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120472
Published online Sep 15, 2026. doi: 10.4251/wjgo.120472

Full Size Figure Download Figure

Figure 1 Pathophysiology of irinotecan and 5-fluorouracil on ileal membrane phospholipid when enriched with eicosapentaenoic acid and docosahexaenoic acid. CPT-11: Irinotecan; 5-FU: 5-fluorouracil; AA: Arachidonic acid; PLA₂: Phospholipase A₂; LOX: Lipoxygenase; COX: Cyclooxygenase; HETE: Hydroxyeicosatetraenoic acid; LTB₄: Leukotriene-B₄; PG: Prostaglandin; TX: Thromboxane; DHA: Docosahexaenoic acid; EPA: Eicosapentaenoic acid; NE: Non-enzymatic; CYP: Cytochrome P450; HDoHE: Hydroxy-docosahexaenoic acid.

Citation: Parsons SR, Rivas-Serna IM, Clandinin MT, Mazurak VC. Dietary eicosapentaenoic and docosahexaenoic acids decrease prostanoids in the ileum of rats treated with irinotecan and 5-fluorouracil. World J Gastrointest Oncol 2026; 18(9): 120472
URL: https://www.wjgnet.com/1948-5204/full/v18/i9/120472.htm
DOI: https://dx.doi.org/10.4251/wjgo.120472

Parsons SR, Rivas-Serna IM, Clandinin MT, Mazurak VC. Dietary eicosapentaenoic and docosahexaenoic acids decrease prostanoids in the ileum of rats treated with irinotecan and 5-fluorouracil. World J Gastrointest Oncol 2026; 18(9): 120472 [DOI: 10.4251/wjgo.120472]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.